Clinical Trials Browser

Cholangiocarcinoma × Yttrium-90 × 90 days × Clear all

NCT05655949 2026-04-22

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Phase 2 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma